» Articles » PMID: 36244878

The Evolving Epidemiology of Monkeypox Virus

Overview
Date 2022 Oct 16
PMID 36244878
Authors
Affiliations
Soon will be listed here.
Abstract

Monkeypox, caused by the monkeypox virus (MPXV), is a zoonotic disease endemic mainly in West and Central Africa. As of 27 September 2022, human monkeypox has occurred in more than 100 countries (mostly in non-endemic regions) and caused over 66,000 confirmed cases, which differs from previous epidemics that mainly affected African countries. Due to the increasing number of confirmed cases worldwide, the World Health Organization (WHO) has declared the monkeypox outbreak as a Public Health Emergency of International Concern on July 23, 2022. The international outbreak of human monkeypox represents a novel route of transmission for MPXV, with genital lesions as the primary infection, and the emergence of monkeypox in the current outbreak is also new, as novel variants emerge. Clinical physicians and scientists should be aware of this emerging situation, which presents a different scenario from previous outbreaks. In this review, we will discuss the molecular virology, evasion of antiviral immunity, epidemiology, evolution, and detection of MPXV, as well as prophylaxis and treatment strategies for monkeypox. This review also emphasizes the integration of relevant epidemiological data with genomic surveillance data to obtain real-time data, which could formulate prevention and control measures to curb this outbreak.

Citing Articles

Approaches to Next-Generation Capripoxvirus and Monkeypox Virus Vaccines.

Williamson A Viruses. 2025; 17(2).

PMID: 40006941 PMC: 11861168. DOI: 10.3390/v17020186.


Clinical manifestations and pathogenicity of Clade IIb monkeypox virus in rabbits.

Shang C, Shi S, Jiang Q, Wang X, Yao X, Li W Emerg Microbes Infect. 2025; 14(1):2465309.

PMID: 39945750 PMC: 11849023. DOI: 10.1080/22221751.2025.2465309.


Navigating monkeypox: identifying risks and implementing solutions.

Aryaloka S, Khairullah A, Kusala M, Fauziah I, Hidayatik N, Agil M Open Vet J. 2025; 14(12):3144-3163.

PMID: 39927376 PMC: 11799651. DOI: 10.5455/OVJ.2024.v14.i12.1.


Mpox: Global epidemic situation and countermeasures.

Hou W, Wu N, Liu Y, Tang Y, Quan Q, Luo Y Virulence. 2025; 16(1):2457958.

PMID: 39921615 PMC: 11810083. DOI: 10.1080/21505594.2025.2457958.


Single-cell sequencing of peripheral blood mononuclear cells reveals immune landscape of monkeypox patients with HIV.

Liu Y, Liu X, Wang J, Xie Y, Guo J, Liu Z Emerg Microbes Infect. 2025; 14(1):2459136.

PMID: 39868995 PMC: 11809181. DOI: 10.1080/22221751.2025.2459136.


References
1.
Kennedy J, Gurwith M, Dekker C, Frey S, Edwards K, Kenner J . Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults. J Infect Dis. 2011; 204(9):1395-402. PMC: 3218648. DOI: 10.1093/infdis/jir527. View

2.
Yinka-Ogunleye A, Aruna O, Dalhat M, Ogoina D, McCollum A, Disu Y . Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report. Lancet Infect Dis. 2019; 19(8):872-879. PMC: 9628943. DOI: 10.1016/S1473-3099(19)30294-4. View

3.
Chen Y, Li M, Fan H . The monkeypox outbreak in 2022: adaptive evolution associated with APOBEC3 may account for. Signal Transduct Target Ther. 2022; 7(1):323. PMC: 9481568. DOI: 10.1038/s41392-022-01181-x. View

4.
Ogoina D, Iroezindu M, James H, Oladokun R, Yinka-Ogunleye A, Wakama P . Clinical Course and Outcome of Human Monkeypox in Nigeria. Clin Infect Dis. 2020; 71(8):e210-e214. DOI: 10.1093/cid/ciaa143. View

5.
Hobson G, Adamson J, Adler H, Firth R, Gould S, Houlihan C . Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom, May 2021. Euro Surveill. 2021; 26(32). PMC: 8365177. DOI: 10.2807/1560-7917.ES.2021.26.32.2100745. View